Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 9UNKNOWN 2NIH 2NETWORK 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1

Interventions

S 1 (combination) 7Cisplatin 7Radiotherapy, Intensity-Modulated 5Paclitaxel 5Oxaliplatin 3Irinotecan 3Capecitabine 3titanium silicide 2raltitrexed 2nimotuzumab 2nabiximols 2Radiotherapy 2Radiation Dose Hypofractionation 2pegylated granulocyte colony-stimulating factor 1nedaplatin 1icaritin 1gimeracil 1anlotinib 1Trastuzumab 1Temozolomide 1Tegafur 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1Radiation 1Pharmaceutical Preparations 1Pemetrexed 1Ondansetron 1Methylene Blue 1Lidocaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × UNKNOWN × raltitrexed × Clear all
NCT02992886 2021-09-09

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

ChineseAMS

Phase 2 Completed
68 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03083613 2021-02-01

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

ChineseAMS

Phase 2 Completed
41 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡